"As an experienced fund investor with 10 participations across the world, Solvay decided to renew its financial commitment and fruitful partnership with PVP. We really look forward to engaging with start ups developing breakthrough technologies thanks to the unparalleled deal flow provided."
- Stéphane Roussel, Managing Director of Solvay Ventures
"The closing of the PVP II LP is a testament to Phoenix Venture Partners investment strategy in advanced material innovation. This investment has exposed Pfizer to significant and strategically important technologies that would not have been on our radar screen. We are looking forward to a continued productive relationship with PVP II.”
- Barbara Dalton, Vice President, Venture Capital, Worldwide Business Development & Innovation at Pfizer, Inc.
“We appreciate PVP’s performance and capability based on our cooperation in the prior fund since 2010. Even for leading global corporations, to achieve new business growth, it is crucial to build partnership with new ventures that are dedicated to developing advanced technologies. We recognize this and are very enthusiastic to enhance our network through our continued alliance with PVP.”
Dr. Katsuyuki Tsuji, General Manager of Corporate R&D Department at Showa Denko K.K.
“Eastman chose to partner with PVP due to its focus on advanced materials venture investing, its deal flow screening based on partnership business models and its closely collaborative approach with its strategic limited partners. In addition, we believe PVP brings a good cultural fit with Eastman.”
- Brendan Boyd, External Innovation Director at Eastman Chemical Company
“The partnership with Phoenix Venture Partners has given us the opportunity to gain valuable strategic insights into various markets and access to leading-edge material science technologies to help us continue to find innovative solutions for our customers.”
- Ryan Takeuchi, W.L. Gore & Associates